glutathione autism pathway A mathematical model of metabolism | Theoretical Biology and Medical Modelling Glutathione and Autism: Evidence-Based Overview

Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options

10.1016/s0065-2660(03)48000-0 Adv

18 BPC-157 is claimed to have beneficial effects even outside the gastrointestinal tract

doi: 10.1016/j.arr.2023.102165, 4